Intelligence Platform
Patents
Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6630170
Mesoporous compositions and method of preparation
expired patentUS 6627731
Thrombin derived polypeptides; compositions and methods for use
expired patentUS 6627189
Inhibition of cellular proliferation using ras antisense molecules
expired patentUS 6623957
Secretion of T cell receptor fragments from recombinant host cells
expired patentUS 6613757
COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT
expired patentUS 6608026
Apoptotic compounds
expired patentUS 6602975
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-r
expired patentUS 6596296
Drug releasing biodegradable fiber implant
expired patentUS 6593306
Methods for modulation and inhibition of telomerase
expired patentUS 6586242
TAO protein kinases and methods of use therefor
expired patentUS 6582725
Human PEA3 is a tumor suppressor for cancer cells
expired patentUS 6579893
Use of troglitazone and related compounds for the treatment of cancer
expired patentUS 6576264
Insoluble drug delivery
expired patentUS 6566500
Compositions and methods for modifying toxic effects of proteinaceous compounds
expired patentUS 6562801
PpGpp and pppGpp as immunomodulatory agents
expired patentUS 6551830
Rh blood group antigen compositions and methods of use
expired patentUS 6551774
Diagnostic methods for conditions associated with elevated cellular levels of telomerase a
expired patentUS 6537804
BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated c
expired patentUS 6524583
Antibody methods for selectively inhibiting VEGF
expired patentUS 6518063
Osf2/Cbfa1 nucleic acids and methods of use therefor
expired patentUS 6517828
C-CAM as an angiogenesis inhibitor
expired patentUS 6515118
DNA fragmentation factor
expired patentUS 6514942
Methods and compositions for stimulating T-lymphocytes
expired patentUS 6511847
Recombinant p53 adenovirus methods and compositions
expired